This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Aflac Incorporated was formed in 1973 under the laws of the state of Georgia. The company is a general business holding company and oversees the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States (Aflac U.S.) and, effective Apr 1, 2018, through Aflac Life Insurance Japan Ltd. in Japan (Aflac Japan).
Globe Life Is Trading at a Discount: Time to Load Up or Hold Off?
by Zacks Equity Research
GL builds on niche markets and agency expansion to boost premiums but rising expenses and higher debt weigh on margins.
Zacks Industry Outlook Highlights Aflac, Trupanion and Globe Life
by Zacks Equity Research
Zacks highlights Aflac, Trupanion, and Globe Life as key stocks in the accident & health insurance industry, which faces pricing pressure but benefits from tech adoption, underwriting strength, and growing demand.
3 Accident & Health Insurance Stocks to Watch Amid Pricing Pressure
by Tanuka De
Accident and Health Insurance stocks like AFL, TRUP and GL are set to gain from rising underwriting exposure and accelerated digitalization. However, pricing pressure is a concern given rising medical costs and inflation.
Berkshire Boosts Mitsubishi Stake, Increases Investment in Japan
by Tanuka De
Berkshire lifts its Mitsubishi stake to 10.23%, deepening its Japan bet with rising dividends, low-cost debt and governance gains.
Here's How Much a $1000 Investment in Aflac Made 10 Years Ago Would Be Worth Today
by Zacks Equity Research
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
Why Berkshire Hathaway is Expanding Its Investments in Japan?
by Tanuka De
BRK.B deepens its Japan bets with $23.5B stakes, yen bonds, and rising dividends fueling long-term growth.
Top Analyst Reports for NVIDIA, Cisco & Linde
by Mark Vickery
NVIDIA, Cisco and Linde post strong gains as analysts spotlight AI growth, software expansion and industrial gas leadership.
All You Need to Know About Aflac (AFL) Rating Upgrade to Buy
by Zacks Equity Research
Aflac (AFL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
GL Outperforms Industry, Trades Above 50-Day SMA: What's Next?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.
Unum to Benefit From Growing Premium Amid Rising Expenses
by Zacks Equity Research
Unum Group sees Q2 premium gains, but rising costs, margin pressure, and weak ROE temper its performance.
Aflac Loads the Buyback Cannon as New Sales Signal Strength
by Kaibalya Pravo Dey
AFL boosts its buyback plan to 130.9M shares as strong sales in Japan and higher U.S. margins fuel shareholder returns.
Aflac Q2 Earnings Beat Estimates on Solid Cancer Product Sales
by Zacks Equity Research
AFL's Q2 earnings benefit from robust Japan cancer insurance sales and strong persistency rates in the U.S. business, partly offset by rising costs.
Here's What Key Metrics Tell Us About Aflac (AFL) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Aflac (AFL) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Aflac (AFL) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Aflac (AFL) delivered earnings and revenue surprises of +4.09% and +2.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
What to Expect From These 4 Insurers This Earnings Season?
by Sushmita Sarker
Here, we take a look at four insurance stocks, AFL, LMND, HRTG and AIZ, which are set to report second-quarter earnings on Aug. 5.
Aflac Gears Up for Q2 Earnings: Ready to Quack or Set to Crack?
by Zacks Equity Research
AFL braces for Q2 results with EPS likely to decline 6.6% and revenue off 13.7% as U.S. and Japan earnings face pressure.
Applied Digital's Q4 Earnings & Revenues Meet Estimates, Stock Up
by Zacks Equity Research
APLD's fiscal Q4 revenues rose 41%, and major CoreWeave contracts helped drive a sharp pre-market stock rally.
Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gear Up for Aflac (AFL) Q2 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Aflac (AFL) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Unum (UNM) Lags Q2 Earnings Estimates
by Zacks Equity Research
Unum (UNM) delivered earnings and revenue surprises of -7.17% and +1.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Aflac (AFL) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Aflac (AFL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can ACGL's New Health Suite Boost Growth and Expand Market Reach?
by Zacks Equity Research
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
Do Options Traders Know Something About Aflac Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to AFL stock based on the movements in the options market lately.
UNM Outperforms Industry, Trades at a Premium: Should You Buy the Stock?
by Zacks Equity Research
Unum Group outperforms in 2025 as core segments expand and the stock trades at a discount to the industry average.
GL Stock Trading at a Discount to Industry at 8.22X: Time to Hold?
by Zacks Equity Research
Globe Life is set to grow on well-performing American Income and Liberty National divisions, higher invested assets and a strong liquidity position.